Gestalt (Decision/Risk Analysis) Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$7.5M
- Investors
-
15
Gestalt (Decision/Risk Analysis) General Information
Description
Developer of a software platform designed to bring the benefits of digital workflow to pathologists and pathology laboratories. The company provides digital pathology using advanced technology, proven digital expertise, and artificial intelligence, enabling pathologists to diagnose diseases faster and more efficiently.
Contact Information
Website
www.gestaltdiagnostics.comCorporate Office
- 850 East Spokane Falls Boulevard
- Suite 135
- Spokane, WA 99202
- United States
Corporate Office
- 850 East Spokane Falls Boulevard
- Suite 135
- Spokane, WA 99202
- United States
Gestalt (Decision/Risk Analysis) Timeline
Gestalt (Decision/Risk Analysis) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 28-Apr-2025 | $7.5M | Completed | Generating Revenue | ||
| 5. Grant | 29-Apr-2024 | Completed | Generating Revenue | |||
| 4. Seed Round | 15-Apr-2021 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 16-Mar-2017 | $2.75M | $2.75M | Completed | Generating Revenue | |
| 1. Joint Venture | 01-Jan-2015 | $500K | Completed | Startup |
Gestalt (Decision/Risk Analysis) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 3,243,000 | $0.000100 | $1 | $1 | 1x | $1 | 11.77% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Gestalt (Decision/Risk Analysis) Comparisons
Industry
Financing
Details
Gestalt (Decision/Risk Analysis) Competitors (6)
One of Gestalt (Decision/Risk Analysis)’s 6 competitors is Deep Bio, a Venture Capital-Backed company based in Seoul, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Deep Bio | Venture Capital-Backed | Seoul, South Korea | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Paige | Formerly VC-backed | New York, NY | ||||
| Techcyte | Venture Capital-Backed | Orem, UT | ||||
| Proscia | Formerly VC-backed | Philadelphia, PA |
Gestalt (Decision/Risk Analysis) Patents
Gestalt (Decision/Risk Analysis) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1113948-S1 | Display screen or portion thereof with an animated graphical user interface | Active | 15-Mar-2024 | ||
| EP-4276846-A1 | Enhanced digital pathology platform | Pending | 10-May-2022 | ||
| GB-202306821-D0 | Enhanced digital pathology platform | Pending | 10-May-2022 | ||
| GB-2620669-A | Enhanced digital pathology platform | Pending | 10-May-2022 | ||
| US-12272026-B2 | Enhanced digital pathology platform | Active | 10-May-2022 | G06T5/50 |
Gestalt (Decision/Risk Analysis) Signals
Gestalt (Decision/Risk Analysis) Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TechVision Fund | Venture Capital | Minority | ||
| Health Sciences & Services Authority of Spokane County | Government | |||
| Believe in Me Foundation | Corporation | Minority | ||
| Puget Sound Venture Club | Angel Group | Minority | ||
| Sun Mountain Capital | Venture Capital | Minority |
Gestalt (Decision/Risk Analysis) Acquisitions (1)
Gestalt (Decision/Risk Analysis)’s most recent deal was a Merger/Acquisition with Peak Medical Technologies. The deal was made on 04-Feb-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Peak Medical Technologies | 04-Feb-2019 | Merger/Acquisition | Enterprise Systems (Healthcare) |
Gestalt (Decision/Risk Analysis) FAQs
-
When was Gestalt (Decision/Risk Analysis) founded?
Gestalt (Decision/Risk Analysis) was founded in 2015.
-
Where is Gestalt (Decision/Risk Analysis) headquartered?
Gestalt (Decision/Risk Analysis) is headquartered in Spokane, WA.
-
What is the size of Gestalt (Decision/Risk Analysis)?
Gestalt (Decision/Risk Analysis) has 34 total employees.
-
What industry is Gestalt (Decision/Risk Analysis) in?
Gestalt (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.
-
Is Gestalt (Decision/Risk Analysis) a private or public company?
Gestalt (Decision/Risk Analysis) is a Private company.
-
What is the current valuation of Gestalt (Decision/Risk Analysis)?
The current valuation of Gestalt (Decision/Risk Analysis) is .
-
What is Gestalt (Decision/Risk Analysis)’s current revenue?
The current revenue for Gestalt (Decision/Risk Analysis) is .
-
How much funding has Gestalt (Decision/Risk Analysis) raised over time?
Gestalt (Decision/Risk Analysis) has raised $14.1M.
-
Who are Gestalt (Decision/Risk Analysis)’s investors?
TechVision Fund, Health Sciences & Services Authority of Spokane County, Believe in Me Foundation, Puget Sound Venture Club, and Sun Mountain Capital are 5 of 15 investors who have invested in Gestalt (Decision/Risk Analysis).
-
Who are Gestalt (Decision/Risk Analysis)’s competitors?
Deep Bio, Ibex Medical Analytics, Paige, Techcyte, and Proscia are some of the 6 competitors of Gestalt (Decision/Risk Analysis).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process